Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study

Publication Type:

Journal Article

Source:

Hepatology, Volume 64, Issue 2, p.370-380 (2016)
Top